Filing Details
- Accession Number:
- 0001562180-25-004057
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-20 19:48:14
- Reporting Period:
- 2025-05-16
- Filing Date:
- 2025-05-20
- Accepted Time:
- 2025-05-20 19:48:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1459839 | Si-Bone Inc. | SIBN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1218802 | Laura Francis | C/O Si-Bone, Inc. 471 El Camino Real, Suite 101 Santa Clara CA 95050 | Chief Executive Officer | No | No | No | No |
Transaction Summary
| Sold: | 17,797 shares | Avg. Price: $19.62 | Total Value: $349,134.00 |
| Number of Shares After Transactions: | 490,987 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-05-16 | 250 | $20.01 | 506,511 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-16 | 2,028 | $19.69 | 504,483 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-16 | 3,785 | $19.66 | 500,698 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-16 | 3,097 | $19.68 | 497,601 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-16 | 100 | $20.01 | 497,501 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-16 | 100 | $20.01 | 497,401 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-16 | 2,231 | $19.68 | 495,170 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-16 | 794 | $19.48 | 496,399 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-19 | 5,412 | $19.49 | 490,987 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 302,958 | Indirect | by Trust |
Footnotes
- The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- Includes 418,615 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- Shares held by The David & Laura Joint Rev Tr.
- This transaction was executed in multiple trades at prices ranging from $20.00 USD to $20.01 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This transaction was executed in multiple trades at prices ranging from $19.01 USD to $20.005 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This transaction was executed in multiple trades at prices ranging from $19.00 USD to $19.96 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This transaction was executed in multiple trades at prices ranging from $19.01 USD to $20.00 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This transaction was executed in multiple trades at prices ranging from $18.98 USD to $19.955 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $19.26 USD to $19.64 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Includes 2,023 shares acquired under the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on May 15, 2025.
Billionaire Hedge Funds
